Recent Headlines
Within Pharmaceuticals
Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program
Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners
Molekule Consulting Announces the Launch of E.U. - Based Operations
Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting
Baltimore Innovation Invited You to Come and Meet Them for Coffee
Baltimore Innovations staff was present at Pharmapack in Paris on the 18 May 2022. This show is a popular event for the pharmaceutical packaging industry, and a great way to get new ideas from all over the world. Baltimore Innovations’ Global Sales Director Philippe Depois was in attendance... - May 24, 2022 - Baltimore Innovation
ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station
The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl
Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology
LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells
In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic
NuvOx Pharma Announces Issuance of a New Patent
NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof.” - May 19, 2022 - NuvOx Therapeutics
North American Pet Insurance Market More Than Doubles in Four Years
The North American Pet Health Insurance Association (NAPHIA) announced that the pet insurance sector exceeded $2.83 B USD at year end 2021, and industry growth more than doubled over the past four years (2018 - 2021). NAPHIA’s 2022 State of the Industry Report shows a record $2.837 billion USD in total in-force premiums in 2021 (up over 30.5% from $2.175 billion USD in 2020) and over 4.41 million insured pets across North America (up 27.7% from over 3.45 million pets insured in 2020). - May 17, 2022 - NAPHIA - North American Pet Health Insurance Association
M&M Labs President and CEO Launches WellRabbit, a Physician-Vetted Supplement Website That Promotes Health and Wellness
The President and CEO of South Carolina and North Carolina-based M&M Labs, a physician-driven company that formulates, manufactures, and distributes nutraceutical products, is announcing the launch of a new supplement website. Dr. Jeffrey Hendricks is one of four founders of WellRabbit, an... - May 16, 2022 - WellRabbit
Intrinsica Announces Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge
Today, Intrinsica Inc., a non-profit organization, announced the dates for the RAPID Alliance 2.0 Launch Meeting and Innovation Acceleration Forum for solving a $528 billion dollar medications use challenge affecting 200 million or more people in the US. The event is occurring on June 21 and 22, 2022, virtually. The event is designed to bring together a select group of leaders, scholars, innovators, funders, technologists, government leaders and others from across the US medications sector. - May 13, 2022 - Intrinsica, Inc.
NuvOx Appoints Dr. Robert King to SAB
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, appointed Dr. Robert King to its Scientific Advisory Board (SAB). Dr. King is a seasoned life science executive with over 30 years’... - May 11, 2022 - NuvOx Therapeutics
CMR Institute's Board of Directors Welcomes New Board Member
CMR Institute's Board of Directors recently held their annual meeting and selected new leadership, along with voting in a new board member, Andrew Krumerman, MD. Andrew Krumerman, MD, is an Attending Physician in the Division of Cardiology and Division of Cardiac Electrophysiology at Montefiore,... - May 10, 2022 - CMR Institute
Cmr Institute's Board of Directors Vote on New Chairman, Vice Chair
CMR Institute's Board of Directors recently held their annual meeting and selected new leadership, electing Dr. Jeffrey Farber as Chairman of the Board and Dr. Mark Sorrentino as the Vice-Chair. Jeffrey Farber, MD, MBA, FACP, a board-certified geriatrician and internist, is the President and CEO... - May 10, 2022 - CMR Institute
Terrain Health Expands, Offering Innovative Solutions to Patients in Direct Patient Care and in Natural and Effective Fertility Solutions
Terrain Health, an international, precision healthcare organization focusing on integrative and functional medicine utilizing next generation healthcare tools, is pleased to announce they are expanding their practice to best meet the needs of its patients. Terrain Health is now offering Direct... - May 09, 2022 - Terrain Health Inc.
The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS
The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute
Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek
Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022 - ALS Therapy Development Institute
Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies
Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. - April 30, 2022 - Creative Diagnostics
“Fight ALS Film Fest” Aims to Shine a Spotlight on the World of ALS
Films explore universal themes of life-changing diseases through examination of ALS. Films and dialogue aim to improve understanding, uplift those affected, and expand the community. - April 25, 2022 - ALS Therapy Development Institute
BioSource Celebrating 25 Years in Business
This May marks 25 years since the start of BioSource Cultures & Flavors Inc. Support, guidance, and friendship of customers have made this milestone possible. Since 1997, BioSource has grown organically, as a family business started by Dr. Narayan Suresh and his wife Archana Suresh as... - April 23, 2022 - BioSource Cultures and Flavors
American Laboratory Products Company Merges with GeneProof
American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader... - April 21, 2022 - ALPCO
Microvascular Therapeutics Finalizes Facility Certification for the Production of Its Product, MVT-100
Microvascular Therapeutics (MVT), a clinical stage biotechnology company, finalized its manufacturing facility certifications for the GMP production of its first product, MVT-100. - April 21, 2022 - Microvascular Therapeutics, Inc.
NuvOx Technology Featured in Prominent Peer Review Journal
NuvOx Pharma’s technology, which is developed as a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, was featured in the prominent journal of Frontiers of Neurology. - April 19, 2022 - NuvOx Therapeutics
NuvOx Finalizes Facility Certification, Poising for Phase IIb Trials
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, finalized its manufacturing facility certifications for Phase IIb trials. - April 17, 2022 - NuvOx Therapeutics
River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates
Arkansas has always been a state known for finding diamonds; just maybe not the kind that are coming out of Fort Smith recently. River Valley Relief Cultivation (“RVR”) has been hard at work producing live diamonds, among other live resin extracts, that were released to many Arkansas... - April 15, 2022 - River Valley Relief
Adventist Health Simi Valley and Moorpark Community College Have Entered Into an Exclusive Multi-Year Partnership
Adventist Health Simi Valley is going directly into the community to provide care outside the walls of the hospital. - April 13, 2022 - Adventist Health
Dr. Claudia C. Cotca of C3 Think Tank Appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health
Dr. Claudia C. Cotca of C3 Think Tank appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health. Together with leadership and military health experts, stakeholders and program officers, Dr. Claudia C Cotca will help support and contribute to the scope and mission of ATARC’s Warfighter Health in incorporating responsibly artificial intelligence in military medicine. - April 13, 2022 - C3 Think Tank
Biolexis Therapeutics Announces Poster Presentation at AACR 2022 Annual Meeting
Biolexis Therapeutics Inc., a leader in bio-tech research and creator of the FIELDS™ process, today announced that data highlighting an orally available, CDK9 selective small molecule inhibitor showing promise in n-Myc-driven neuroendocrine prostate cancers (NEPC) was presented in a poster at... - April 11, 2022 - Biolexis Therapeutics Inc.
CredentialingOne – New Credentialing Outsourcing Company Powered by HealthWare Systems
The credentialing outsourcing company CredentialingOne combines HealthWare Systems automation technology with the expertise of Credentialing Specialists. - April 10, 2022 - HealthWare Systems
Degree Controls Integrates Airflow Monitors and Calibrated Anemometers
Degree Controls integrates airflow monitors and calibrated anemometers for fume hood certification using automated entry of face velocity measurements. - April 09, 2022 - Degree Controls
Microvascular Therapeutics Receives Funds from Commercialization Readiness Program for the Development of Its Ultrasound Contrast Agent, MVT-100
MicrovMicrovascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Commercialization Readiness Program grant from the National Institute of Heart, Lung, and Blood Institute (NHLBI). Wyatt Unger, MD, MBA, Chief Medical Officer of MVT said, “We are... - April 09, 2022 - Microvascular Therapeutics, Inc.
Instant Systems Expands Its Footprint in Virginia
Instant Systems continues to expand their footprint in Southeast Virginia with the launch of their Central Supply and Order Fulfilment Center (N3) in Virginia Beach, VA. Increased demand for Instant Systems’ products and services is driving the need for more warehouse, production and R&D... - April 07, 2022 - Instant Systems
Tavicare Presents Pioneering COVID-19 Monoclonal Antibody IV Therapy for High-Risk Patients in MD
The state of Maryland Health Department has selected the medical facility to provide the antibody therapy IV to affected patients. - April 06, 2022 - Tavicare Inc
Yavari LLC Earns NABP Drug Distributor Accreditation
Yavari LLC has earned Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®). NABP’s Drug Distributor Accreditation is a resource for industry and regulatory bodies that establish uniform safeguards meant to protect the public health. Drug... - April 03, 2022 - Yavari LLC
Pipelinepharma Marketplace Records Quadruple Growth Over a Single Year
The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category. New finished dosage form categories for medical devices and nutraceuticals will also be launched in the coming months. - April 01, 2022 - Pipelinepharma
Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens
Creative Diagnostics recently launches a range of natural and recombinant staphylococcal enterotoxin antigens. - March 31, 2022 - Creative Diagnostics
Female Founded Company Launches New Subscription Box in Portland: The Period Releaf Box™
The Period Releaf Box - a complete set of natural supplements with one goal, conquering your period; Prepare your body for the inevitable before the symptoms begin. - March 23, 2022 - Releaf Box
New Product for Solar Cells from Solaris Chem (Canada)
Solaris Chem expands its product offering for solar cell applications. - March 19, 2022 - Solaris Chem Inc.
Solaris Chem Products Are Now Available in Germany Through Hözel
Their distribution partner in Germany, Hözel, has included Solaris Chem's products to its range for the biotechnology sector. Hözel has been a well-established company since its foundation in 1993. Thanks to its long-standing market presence, it has a lot of experience and knowledge in... - March 19, 2022 - Solaris Chem Inc.
ALPCO Announced Its Support of the Ukrainian People in a Company-Wide Communication to Its Employees
ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an... - March 16, 2022 - ALPCO
Femometer Donates Medical Equipment to NGOs Across U.S.
Femometer, a division of Lollipop Technology Hangzhou Co. Ltd. donates over 5,000 thermometers to a number of NGOs based in the U.S. to support medical supply shortages caused by the COVID-19 pandemic. The list of NGOs who received donations includes CURE International, Food For The Poor, Famidi... - March 12, 2022 - Lollipop Technology Hangzhou Ltd. Co.
Pennsylvania Institute of Technology Welcomes New Dean of Academic Affairs, Dr. Heather Pfleger, Ed.D
The Pennsylvania Institute of Technology in Media has ended a two-month search for its next Dean of Academic Affairs and Accreditation Liaison with the hiring of Dr. Heather Pfleger, Ed.D. She started her new role on Feb. 28. The P.I.T. community invested over 60 work hours in the search, looking... - March 10, 2022 - Pennsylvania Institute of Technology
Tavicare Offers Award-Winning Care for Feminine Health Problems
“The 'big picture' approach isn’t just about looking at disease or dysfunction — it’s about looking at a patient in their entirety,” declares Dr. Tavakoli. - March 07, 2022 - Tavicare Inc
Hormonal Treatments by TaviCare is Enabling People to Live Their Life to the Fullest in Chevy Chase, Maryland
Tavicare, a Maryland based medical facility, is helping people with medical conditions through its wide range of medical treatments - March 07, 2022 - Tavicare Inc
NuvOx Receives Notice from the Breakthrough DOD Award for Its Immuno-Oncology Program
On February 11th, 2022, NuvOx Pharma received notice from the Department of Defense (DOD) office of the Congressionally Directed Medical Research Programs (CDMRP) that the Company has been awarded a grant from the Breast Cancer Research Program Breakthrough Award. The grant would fund a... - March 05, 2022 - NuvOx Therapeutics
Tavicare’s Advanced GAPS Diet Protocol is Helping Patients Get Remarkable Results in as Little as Six Months
Now patients don’t have to wait for years to cure their chronic or urgent health problems with Tavicare’s carefully tailored GAPS protocol. - March 04, 2022 - Tavicare Inc
Johari Digital Expands Its Horizons for Better Healthcare
Johari Digital Healthcare Ltd. is glad to announce that Johari Digital is expanding to Medical Device Park, Jodhpur, Rajasthan, India. With the expansion, Johari Digital will triple its capacity to uptake challenging projects. Johari welcomes projects from startups as well as Global Med-Tech companies. - March 04, 2022 - Johari Digital Healthcare Ltd.
The Daily Record Announces 2022 Leaders in Law
Brian S. Brown Honored Among the 2022 Leaders in Law by The Daily Record & MSBA.The annual Leadership in Law awards pay tribute to all the ways in which legal professionals are serving businesses, clients and individuals across Maryland and making communities stronger. - March 03, 2022 - Brown & Barron
Thrivous Introduces Personalized Medicine Coaching
Thrivous, the human enhancement company, has partnered with Consolidated Health Solutions to provide personalized medicine coaching. Thrivous' mission is to help customers access technology with the greatest potential to improve their brains and bodies. Customers may achieve better results when... - March 03, 2022 - Thrivous
Locus Fermentation Solutions Selected for Evolution of Manufacturing Award by Smart Business Magazine
Northeast Ohio startup recognized for its innovative biological manufacturing with a near-zero carbon footprint. - February 27, 2022 - Locus Fermentation Solutions
FOXG1 Research Foundation Hosts Napa Valley Charity Golf Tournament to Accelerate Research for Pediatric Neurological Disorder
Scientists believe FOXG1 may hold the key to unlocking brain disorders affecting millions, including autism, Alzheimer’s, brain tumors and more. - February 23, 2022 - FOXG1 Research Foundation